Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Activities of eight new beta-lactam antibiotics and seven antibiotic combinations against Neisseria meningitidis.

Literature DB >> 6805425

Activities of eight new beta-lactam antibiotics and seven antibiotic combinations against Neisseria meningitidis.

R K Scribner, B C Wedro, A H Weber, M I Marks.

Abstract

Each of eight new beta-lactam antibiotics was highly active in vitro against Neisseria meningitidis, and activity was not reduced by combining some of these drugs with penicillin, ampicillin, or tobramycin. Antibacterial activity and lack of antagonism between moxalactam and ampicillin was confirmed in a model of lethal meningococcal infection in mice.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1982 PMID： 6805425 PMCID： PMC181968 DOI： 10.1128/AAC.21.4.678

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

5 in total

1. Cefotaxime for bacterial meningitis.

Authors: W M Brown; R J Fallon
Journal: Lancet Date: 1979-06-09 Impact factor: 79.321

2. In vitro and in vivo antibacterial activity of cefoperazone.

Authors: S Mitsuhashi; S Minami; N Matsubara; A Yotsuji; S Kurashige; I Saikawa
Journal: Clin Ther Date: 1980 Impact factor: 3.393

3. Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.

Authors: H C Neu; N J Meropol; K P Fu
Journal: Antimicrob Agents Chemother Date: 1981-03 Impact factor: 5.191

4. Antimicrobial activity of cefmenoxime (SCE-1365).

Authors: J M Stamm; R L Girolami; N L Shipkowitz; R R Bower
Journal: Antimicrob Agents Chemother Date: 1981-03 Impact factor: 5.191

5. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.

Authors: T C Eickhoff; J Ehret
Journal: Antimicrob Agents Chemother Date: 1981-03 Impact factor: 5.191

5 in total

11 in total

1. Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3.

Authors: P M Mendelman; J Campos; D O Chaffin; D A Serfass; A L Smith; J A Sáez-Nieto
Journal: Antimicrob Agents Chemother Date: 1988-05 Impact factor: 5.191

2. Isolation of Neisseria meningitidis strains with increase of penicillin minimal inhibitory concentrations.

Authors: J A Sáez-Nieto; D Fontanals; J Garcia de Jalon; V Martinez de Artola; P Peña; M A Morera; R Verdaguer; I Sanfeliu; C Belio-Blasco; J L Perez-Saenz
Journal: Epidemiol Infect Date: 1987-10 Impact factor: 2.451

Review 3. Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors: R N Brogden; A Ward
Journal: Drugs Date: 1988-06 Impact factor: 9.546

Review 4. In vitro activity of imipenem--a review.

Authors: I Braveny
Journal: Eur J Clin Microbiol Date: 1984-10 Impact factor: 3.267

Review 5. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors: D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal: Drugs Date: 1984-06 Impact factor: 9.546

Review 6. Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors: S P Clissold; P A Todd; D M Campoli-Richards
Journal: Drugs Date: 1987-03 Impact factor: 9.546

Review 7. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors: D M Richards; R C Heel
Journal: Drugs Date: 1985-04 Impact factor: 9.546

Review 8. Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors: D M Richards; R N Brogden
Journal: Drugs Date: 1985-02 Impact factor: 9.546

Review 9. Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors: A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal: Drugs Date: 1983-10 Impact factor: 9.546

Review 10. Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors: A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal: Drugs Date: 1983-03 Impact factor: 9.546